Lactose (India) Limited (LACTOSE) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE058I01013
Key metrics
- Market Cap
- ₹126 Cr
- P/E Ratio
- 18.62
- EPS
- 5.39
- Book Value
- 51.47
- P/B Ratio
- 1.95
- ROE
- 9.36%
- ROCE
- 9.93%
- Debt / Equity
- 0.96
- Net Margin
- 3.71%
- Revenue Growth
- 40.28%
- Profit Growth
- 17.43%
- Dividend Yield
- —
- 52W High
- ₹136.70
- 52W Low
- ₹76.01
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Lactose (India) Limited
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 59.76%
The full Lactose (India) Limited analysis
Create a free account to open the complete LACTOSE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.